Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS)
The purpose of this study was to assess the efficacy and safety of the combination of tirofiban with intravenous thrombolysis (IVT) in treating patients with capsular warning syndrome (CWS) who failed to respond to the treatment of intravenous thrombolysis alone. Tirofiban was approved for the treat...
שמור ב:
| Principais autores: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2022-11-01
|
| סדרה: | Frontiers in Neuroscience |
| נושאים: | |
| גישה מקוונת: | https://www.frontiersin.org/articles/10.3389/fnins.2022.1026127/full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|